Genomics, public health and developing countries: The case of the Mexican National Institute of Genomic Medicine (INMEGEN)

Nature Reviews Genetics

Volumn 9, Issue SUPPL.1, 2008, Pages

  Séguin, Béatrice ^a   Hardy, Billie Jo ^a   Singer, Peter A ^a,b   Daar, Abdallah S ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MaRS Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEVELOPING COUNTRY; DISEASE PREDISPOSITION; DRUG RESPONSE; GENE MAPPING; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HEALTH SERVICE; HUMAN GENOME PROJECT; MEDICAL RESEARCH; MEXICO; NATIONAL INSTITUTE OF GENOMIC MEDICINE; POPULATION GENETICS; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW;

ACADEMIES AND INSTITUTES; DEVELOPING COUNTRIES; GENOMICS; MEXICO; PUBLIC HEALTH;

EID: 52149091650     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg2442     Document Type: Review

References (33)

1. Boutayeb, A. The double burden of communicable and non-communicable diseases in developing countries. Trans. R. Soc. Trop. Med. Hyg. 100, 191-199 (2006).
2. Foro Consultivo Científico y Tecnológico. Propuesta de una ley de Ciencia, Tecnología e Innovación. [online], 〈http://www.foroconsultivo.org.mx/documentos/ley_ctei/ segundo_borrador_agosto_2007.pdf〉 (2007) (in Spanish).
3. Séguin, B. & Hardy, B, Singer, P. A. & Daar, A. S. Human genomic variation initiatives in emerging economies and developing countries. Nature Rev. Genet. 9 (Suppl), S3-S4 (2008).
4. Séguin, B. & Hardy, B, Singer, P. A. & Daar, A. S.Genomic medicine and developing countries: creating a room of their own. Nature Rev. Genet. 9, 487-493 (2008).
5. Jimenéz-Sánchez, G. Programa de Trabajo Para Dirigir el Instituto Nacional de Medicina Genomica 2004-2009. INMEGEN [online], 〈http://www.inmegen.gob.mx/images/stories/publicaciones/pdf/prog_trab0409. pdf〉 (2004).
6. Jimenéz-Sánchez, G. Developing a platform for genomic medicine in Mexico. Science 300, 295-296 (2003).
7. Jimenéz-Sánchez, G. & Lara, C. in Panorama Internacional en Salud y Derecho. Culturas y Sistemas Juridicos Comparados (ed. Brena-Sesma, I.) 391 (National Autonomous University of Mexico, Mexico City, Mexico, 2007) (in Spanish).
8. Daar, A. S. & Singer, P. A. Pharmacogenetics and geographical ancestry: implications for drug development and global health. Nature Rev. Genet. 6, 241-246 (2005).
9. Abecasis, G. et al. Human Genome Variation 2006: emerging views on structural variation and large-scale SNP analysis. Nature Genet. 39, 153-155 (2007).
10. Redon, R. et al. Global variation in copy number in the human genome. Nature 444, 444-454 (2006).
11. Becerril, A. Aprueba el Senado sanciones a quienes trasladen tejido humano fuera de México. La Journada [online], 〈http://www. jornada.unam.mx/2008/03/28/index.php?section=sociedad&article= 046n1soc〉 (2008) (in Spanish).
12. Genomics and Benefits Share. Parliamentary Gazette IX, No 1953 (2006).
13. Organisation for Economic Co-operation and Development. How Does Mexico Compare? OECD Health Data 2008 [online], 〈http://www.oecd.org/ dataoecd/46/9/38980018.pdf〉 (2008).
14. Instituto Nacional de Estidística y Geografía. Información estadística. [online], 〈http://www.inegi.gob.mx/ est/contenidos/espanol/rutinas/ept.asp?t=mpob45&c=32〉 (2008) (in Spanish).
15. Lara-Alverez, C. et al. Ethical, legal and social aspects of the Mexican Genomic Variability Project. INMEGEN [online], 〈http://www.inmegen.gob.mx/images/stories/publicaciones/memorias/hugo2007/ lara.pdf〉 (2007).
16. Dalton, R. When two tribes go to war. Nature 430, 500-502 (2004).
17. Dalton, R. Tribe blasts 'exploitation' of blood samples. Nature 420, 111 (2002).
18. Hakimian, R. & Korn, D. Ownership and use of tissue specimens for research. JAMA 292, 2500-2505 (2004).
19. Schmidt, C. W. Indi-gene-ous conflict. Environ. Health Perspect. 109, A216-A219 (2001).
20. Frew, S. E., Sammut, S. M., Siu, W. W., Daar, A. S. & Singer, P. A. The role of the domestic private sector in developing countries for addressing local health needs. Int. J. Biotech. 8, 91-102 (2006).
21. Solleiro, J. L. & Briseno, A. Propiedad intelectual II: el caso de la biotecnologia en Mexico. Interciencia 28, No 2, 90-94 (2003) (in Spanish).
22. Hidalgo-Miranda, A. et al. Proyecto mapa genomico de los Mexicanos. Ciencia y Desarrollo 32, 191 (2006) (in Spanish).
23. Séguin, B., State, L., Singer, P. A. & Daar, A. S. Scientific diasporas as an option for brain drain: re-circulating knowledge for development. Int. J. Biotech. 8, 78 (2006).
24. Séguin, B., Singer, P. A. & Daar, A. S. Science community: scientific diasporas. Science 312, 1602-1603 (2006).
25. Barba, A. México reduce en 6.7% su presupuesto a ciencia. SciDev Net [online], 〈http://www.scidev.net/es/latin-america-and- caribbean/news/mxico-reduce-en-67-su-presupuesto-a-ciencia.html 〉 (2007) (in Spanish).
26. United Nations Development Program. Human Development Report: Making New Technologies Work for Human Development (Oxford University Press, New York, 2001).
27. Juma, C. & Yee-Cheong, L. Reinventing global health: the role of science, technology, and innovation. Lancet 365, 1105-1107 (2005).
28. Acharya, T., Daar, A. S. & Singer, P. A. Biotechnology and the UN's Millennium Development Goals. Nature Biotechnol. 21, 1434-1436 (2003).
29. United Nations Development Programme. The Human Development Index - Going Beyond Income. [online], 〈http://hdrstats.undp.org/countries/ country_fact_sheets/cty_fs_MEX.html〉 (2008).
30. Young, E. & Carrington, D. Cloning pregnancy claim prompts outrage. New Scientist News Service [online], 〈http://www.newscientist.com/ article.ns?id=dn2133〉 (2002).
31. Baker, M. Report casts doubt on Korean experiment. Science 283, 617- 619 (1999).
32. Bosch, X. Mexico to Open Genome Center. Genome Biology Research News [online], 〈http://genomebiology.com/researchnews/default.asp? arx_id=gb-spotlight-20040805-02〉 (2004).
33. Burke, W., Khoury, M. J., Stewart, A., Zimmern, R. L. & Bellagio Group. The path from genome-based research to population health: development of an international public health genomics network. Genet. Med. 8, 451-458 (2006).